Recurrence of Lower Urinary Tract Symptoms Following Prostate Artery Embolization for Benign Hyperplasia: Single Center Experience Comparing Two Techniques

Imagem de Miniatura
Arquivos
art_CARNEVALE_Recurrence_of_Lower_Urinary_Tract_Symptoms_Following_Prostate_2017.PDF (761.43 KB)
Citações na Scopus
38
Tipo de produção
article
Data de publicação
2017
Editora
SPRINGER
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
HARWARD, Sardis Honoria
BHATIA, Shivank
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, v.40, n.3, p.366-374, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
To compare recurrence of lower urinary tract symptoms (LUTS) recurrence at 12 months following original prostate artery embolization (oPAE) or ""proximal embolization first, then embolize distal"" (PErFecTED) PAE for benign prostatic hyperplasia (BPH). 105 consecutive patients older than 45 years, with prostate size greater than 30 cm(3), International Prostate Symptom Score (IPSS) ae<yen> 8, quality of life (QoL) index ae<yen> 3, and refractory status or intolerance of medical management were prospectively enrolled between June 2008 and August 2013. The study was IRB-approved, and all patients provided informed consent. Patients underwent oPAE or PErFecTED PAE and were followed for at least 12 months. Technical success was defined as bilateral embolization and clinical success (non-recurrence) was defined as removal of the Foley catheter in patients with urinary retention, IPSS < 8 and QoL index < 3 at 12 months of follow-up. Nonparametric statistics were used to compare the study groups due to the size of the study population and distributions of clinical data. 97 patients had 12-month data and were categorized as oPAE without recurrence (n = 46), oPAE with recurrence (n = 13), PErFecTED without recurrence (n = 36), or PErFecTED with recurrence (n = 2). Recurrence was significantly more common in oPAE patients (chi (2), p = 0.026). Unilateral embolization was significantly associated with recurrence among patients who underwent oPAE (chi (2), p = 0.032). Both oPAE and PErFecTED PAE are safe and effective methods for treatment of LUTS, but PErFecTED PAE is associated with a significantly lower rate of symptom recurrence.
Palavras-chave
Prostatic artery embolization, Benign prostatic hyperplasia, Lower urinary tract symptoms, International Prostate Symptom Score
URI
https://observatorio.fm.usp.br/handle/OPI/18721
Referências
  1. Abrams P, 1999, BJU INT, V84, P14
  2. Ahyai SA, 2010, EUR UROL, V58, P384, DOI 10.1016/j.eururo.2010.06.005
  3. Amouyal G, 2016, CARDIOVASC INTER RAD, V39, P367, DOI 10.1007/s00270-015-1267-0
  4. Antunes AA, 2013, CARDIOVASC INTER RAD, V36, P978, DOI 10.1007/s00270-013-0611-5
  5. Bachmann A, 2014, EUR UROL, V65, P931, DOI 10.1016/j.eururo.2013.10.040
  6. Bilhim T, 2013, CARDIOVASC INTER RAD, V36, P403, DOI 10.1007/s00270-012-0528-4
  7. Carnevale FC, 2016, CARDIOVASC INTER RAD, V39, P44, DOI 10.1007/s00270-015-1202-4
  8. Carnevale FC, 2014, CARDIOVASC INTER RAD, V37, P1602, DOI 10.1007/s00270-014-0908-z
  9. Carnevale FC, 2013, CARDIOVASC INTER RAD, V36, P1452, DOI 10.1007/s00270-013-0680-5
  10. Carnevale FC, 2013, J VASC INTERV RADIOL, V24, P535, DOI 10.1016/j.jvir.2012.12.019
  11. Carnevale FC, 2011, CARDIOVASC INTER RAD, V34, P1330, DOI 10.1007/s00270-011-0136-8
  12. Carnevale FC, 2010, CARDIOVASC INTER RAD, V33, P355, DOI 10.1007/s00270-009-9727-z
  13. Cornu JN, 2015, EUR UROL, V67, P1066, DOI 10.1016/j.eururo.2014.06.017
  14. de Assis AM, 2015, J VASC INTERV RADIOL, V26, P87, DOI 10.1016/j.jvir.2014.10.012
  15. DeMeritt JS, 2000, J VASC INTERV RADIOL, V11, P767, DOI 10.1016/S1051-0443(07)61638-8
  16. Gao YA, 2014, RADIOLOGY, V270, P920, DOI 10.1148/radiol.13122803
  17. Grosso M, 2015, RADIOL MED, V120, P361, DOI 10.1007/s11547-014-0447-3
  18. Jones P, 2015, UROLOGY, V86, P676, DOI 10.1016/j.urology.2015.05.011
  19. Kurbatov D, 2014, UROLOGY, V84, P400, DOI 10.1016/j.urology.2014.04.028
  20. Laborda A, 2015, CARDIOVASC INTER RAD, V38, P755, DOI 10.1007/s00270-015-1083-6
  21. Lebdai S, 2016, WORLD J UROL, V34, P625, DOI 10.1007/s00345-015-1665-6
  22. Li Q, 2015, CHINESE MED J-PEKING, V128, P2072, DOI 10.4103/0366-6999.161370
  23. McWilliams JP, 2014, J VASC INTERV RADIOL, V25, P1349, DOI 10.1016/j.jvir.2014.05.005
  24. Moreira AM, 2013, CARDIOVASC INTER RAD, V36, P1690, DOI 10.1007/s00270-013-0739-3
  25. National Cancer Institute, NIH PUBL
  26. Nitti NW, 2005, REV UROL S6, V7, pS14
  27. Pisco J, 2013, RADIOLOGY, DOI [10.1148/radiol/12111601, DOI 10.1148/RADIOL/12111601]
  28. Pisco JM, 2013, EUR RADIOL, V23, P2561, DOI 10.1007/s00330-012-2714-9
  29. Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066
  30. Wang MQ, 2016, WORLD J UROL, V34, P1275, DOI 10.1007/s00345-016-1771-0

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - HC/InRad
Carregar mais